Clinical Trial Update: Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating AM-111 for acute sensorineural hearing loss has completed; efficacy results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sensorineural Hearing Loss

Drugs mentioned

• AM-111

Snippet

Sponsor: Auris Medical AG | Conditions: Hearing Loss | Phase 2 | Status: COMPLETED